Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 8 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for BioCryst Pharmaceuticals Inc have a median target of 12.50, with a high estimate of 30.00 and a low estimate of 8.00. The median estimate represents a 66.89% increase from the last price of 7.49.
High | 300.5% | 30.00 |
Med | 66.9% | 12.50 |
Low | 6.8% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 24, 2025.
Average growth rate | +7.51% |
Average growth rate | -7.08% |
More ▼
Revenue history & estimates in USD
Average growth rate | +7.99% |
Average growth rate | +203.39% |
More ▼